Most (11/13; 85%) patients had stage 4 neuroblastoma at diagnosis; one patient had stage 3 neuroblastoma with MYCN amplification, and one was initially classified as stage 4S neuroblastoma but was then reclassified as stage 4 after a subsequent relapse. The gene discussed is MYCN; the disease is neuroblastoma.